Gray Media, Inc.
—- Market cap
- —
- Debt
- +$5.70B
- Cash
- −$368.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: GTN stock price vs CTMX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTMX's multiple
Needs CTMX P/S.
Implied fair value · at GTN's multiple
Needs GTN P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GTN FY 2025 (ended Dec 31, 2025) · CTMX FY 2025 (ended Dec 31, 2025).
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Gray Media, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CytomX Therapeutics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
2.65x
0.17x
Net debt / EBITDA
Leverage against operating earnings
10.01x
-0.27x
Cash and equivalents
Liquid reserves on the balance sheet
$368.00M
$12.67M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEXSTAR MEDIA GROUP, INC.
GTN vs NXST
TEGNA INC
GTN vs TGNA
E.W. SCRIPPS Co
GTN vs SSP
iHeartMedia, Inc.
GTN vs IHRT
Fox Corp
GTN vs FOXA
IDEAYA Biosciences, Inc.
GTN vs IDYA
EXELIXIS, INC.
GTN vs EXEL
GILEAD SCIENCES, INC.
GTN vs GILD
AMGEN INC
GTN vs AMGN
AbbVie Inc.
GTN vs ABBV
BRISTOL MYERS SQUIBB CO
GTN vs BMY
$5.70B
$16.89M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.